Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein

Leukemia and Lymphoma

Volumn 52, Issue 7, 2011, Pages 1302-1311

  Hu, Meng ^a   Liu, Yanping ^a   Deng, Chaohua ^a   Han, Rongfei ^a   Jia, Yanhan ^a   Liu, Shengwu ^a   Jiang, Zhengming ^a   Cao, Xiaochun ^a   He, Liang ^a   Zhang, Qiuping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

cIAP; invasiveness; Multidrug resistance; P gp; PKC

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN KINASE C EPSILON;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL INFILTRATION; CELL INVASION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN LOCALIZATION; SCID MOUSE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; K562 CELLS; LEUKEMIA; MICE; MICE, SCID; NEOPLASM INVASIVENESS; P-GLYCOPROTEIN; PROTEIN BINDING; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79959579765     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.572323     Document Type: Article

References (34)

1. Beesley AH, Cummings AJ, Freitas JR, et al. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 2005;131:447-456. (Pubitemid 43899641)
2. Oh EJ, Kahng J, Kim Y, et al. Expression of functional markers in acute lymphoblastic leukemia. Leuk Res 2003;27: 903-908. (Pubitemid 36809086)
3. Miletti-Gonzalez KE, Chen S, Muthukumaran N, et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 2005;65:6660-6667. (Pubitemid 41060702)
4. Liang Y, McDonnell S, Clynes M. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002;2:257-277.
5. Steinbach D, Legrand O. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia 2007;21:1172-1176. (Pubitemid 46831804)
6. Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106:1154-1163. (Pubitemid 41130866)
7. Drain S, Catherwood MA, Alexander HD. Multidrug resistance in the chronic lymphoproliferative disorders. Leuk Lymphoma 2010;51:1793-1804.
8. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58. (Pubitemid 37328807)
9. Quiney C, Billard C, Faussat AM, Salanoubat C, Kolb JP. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells. Leuk Lymphoma 2007;48:1587-1599. (Pubitemid 47272809)
10. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007;12:1543-1568. (Pubitemid 47106887)
11. Engels K, Knauer SK, Loibl S, et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 2008;68:5159-5166.
12. Vogler M, Giagkousiklidis S, Genze F, Gschwend JE, Debatin KM, Fulda S. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity. Oncogene 2005;24:7190-7202. (Pubitemid 41679281)
13. Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L. Induction of chemoresistance in HL- 60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein. Leukemia 2001;15:1377-1387. (Pubitemid 32785307)
14. Suzuki S, Hayashi H, Takagi K, Kondo T, Ueyama J, Wakusawa S. Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells. Biochim Biophys Acta 2006;1760:1552-1557. (Pubitemid 44428026)
15. Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res 2006;66:9379-9384. (Pubitemid 44623633)
16. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
17. Bao L, Gorin MA, Zhang M, et al. Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer. Cancer Res 2009;69:5829-5834.
18. Aziz MH, Manoharan HT, Church DR, et al. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res 2007;67:8828-8838. (Pubitemid 47437459)
19. Wheeler DL, Ness KJ, Oberley TD, Verma AK. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13- acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Res 2003;63:6547-6555. (Pubitemid 37255210)
20. Lin HH, Chen JH, Chou FP, Wang CJ. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol 2011;162:237-254.
21. Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to downregulation of the tumor suppressor protein PDCD4, antiapoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009;284:26533-26546.
22. Lu Y, Pang T, Wang J, et al. Down-regulation of Pglycoprotein expression by sustained intracellular acidification in K562/Dox cells. Biochem Biophys Res Commun 2008; 377:441-446.
23. Fryknas M, Dhar S, Oberg F, et al. STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer 2007;120:189-195. (Pubitemid 44901935)
24. Banning A, Kipp A, Schmitmeier S, et al. Glutathione peroxidase 2 inhibits cyclooxygenase-2-mediated migration and invasion of HT-29 adenocarcinoma cells but supports their growth as tumors in nude mice. Cancer Res 2008;68: 9746-9753.
25. Redondo-Munoz J, Ugarte-Berzal E, Garcia-Marco JA, et al. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood 2008;112:169-178.
26. Tong X, Zhang L, Hu M, et al. The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin 4. Cell Mol Immunol 2009;6:181-189.
27. Nakagawa Y, Abe S, Kurata M, et al. IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-inducedoverexpression of multidrug resistance genes. Am J Hematol 2006;81:824-831. (Pubitemid 44682183)
28. Che XF, Zheng CL, Owatari S, et al. Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines. Blood 2006;107:4880-4887. (Pubitemid 43882641)
29. Khan S, Aspe JR, Asumen MG, et al. Extracellular, cellpermeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 2009;100: 1073-1086.
30. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 2010;17:53-64.
31. Shi YH, Ding WX, Zhou J, et al. Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology 2008;48:497-507.
32. Matsuo K, Eno ML, Ahn EH, et al. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. Am J Clin Oncol 2010 Oct 1. [Epub ahead of print]
33. Gorin MA, Pan Q. Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer 2009;8:9.
34. Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009;14:2386-2399.